• About
  • Masthead
  • License Content
  • Advertise
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Obstetrics

AAP policy update recommends first-line contraceptives, addresses special populations

byMikhaela MontyandLeah Carr, MD
September 29, 2014
in Obstetrics, Pediatrics, Public Health
Reading Time: 3 mins read
AAP policy update recommends first-line contraceptives, addresses special populations
Share on FacebookShare on TwitterShare on LinkedIn

1. The American Academy of Pediatricians (AAP) recommends that pediatricians offer long-acting reversible contraceptives (LARC) such as the IUD or progestin implants as first line contraceptive methods, given their efficacy and safety.

2. The APP continues to encourage physicians to consistently address sexual health and behavior with their patients and to encourage contraceptive education, use, and compliance. In addition, it is highlighted that patients within “special populations,” such as those with chronic illnesses, have similar contraceptive needs and these illnesses should be addressed in the context of recommending contraception.

Policy Rundown: Greater than 80% of the annual 750 000 pregnancies among U.S. adolescents are unplanned. The AAP recognizes and addresses the need for effective contraception among these adolescents in an effort to decrease unplanned pregnancies and the spread of sexually transmitted infections (STI). In this AAP policy statement, pediatricians are urged to educate themselves on the state laws regarding adolescent consent and confidentiality as well as have an understanding of the efficacy of the available contraceptive methods and their role in the management of certain medical conditions. Pediatricians are encouraged to educate their patients about available contraceptive methods, especially LARC methods, which are most effective at preventing unplanned pregnancy when used in typical manner. The most commonly used methods among US adolescents include condoms, withdrawal, and hormonal birth control pills while the most effective and some of the least utilized methods are LARCs and DMPA injections. This policy statement also highlights the lack of necessity of a pelvic exam prior to prescribing contraceptive methods apart from IUDs. It is recommended that physicians unable to place IUDs be familiar with area providers for easy referral. Pediatricians are encouraged to screen for STIs before prescribing contraception. In addition, patients should be encouraged to regularly use latex condoms with other forms of contraception to prevent STI transmission in addition to pregnancy. Detailed information about specific contraceptive methods including their contraindications, benefits, and side effects can be found in the accompanying technical report.  The AAP recognizes recent attention to the adverse effects of the progestin-only injectable and transdermal patch; however, continues to support their use as these contraceptive methods are safer than pregnancy itself. The APP emphasizes that special populations, such as obese patients and those with chronic medical conditions, have the same sexual health needs as typical adolescents but may require condition-specific consideration when making contraceptive recommendations. Pediatricians are encouraged to regularly follow up with patients with regards to their sexual history and practices in a way that facilitates trust, disclosure, and ultimately safer sex practices.

Click to read the policy statement published today in Pediatrics

Click to read the accompanying technical report in Pediatrics

More from this author: Buprenorphine most responsible for pediatric hospitalizations due to unsupervised ingestion, AAP continues to recommend fluoride for prevention of dental caries, Clinical efficacy of quadrivalent HPV vaccine persists after 8 years, Virtual visits linked to decreased stress in hospitalized children, Early-onset basal cell carcinoma linked to indoor tanning

RELATED REPORTS

Use of semaglutide for weight control among women of reproductive age is more common in those using hormonal contraception

The 2 Minute Medicine Podcast Episode 38

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: birth controlcontraceptionpolicy statement
Previous Post

Vitiligo associated with lower incidence of skin cancers

Next Post

Postresuscitation care may be needed regardless of PPV duration

RelatedReports

Sleep duration inversely related to childhood type 2 diabetes risk makers
Endocrinology

Use of semaglutide for weight control among women of reproductive age is more common in those using hormonal contraception

July 30, 2026
The 2 Minute Medicine Podcast Episode 15
2MM Podcast

The 2 Minute Medicine Podcast Episode 38

April 19, 2024
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Patient Zero: Immunotherapy for Brain Tumors?, Over-the-Counter Birth Control, Florida Supreme Court Deals a Devastating Blow to Abortion Access, Schwarzenegger’s Post-Pacemaker Update on Instagram

April 16, 2024
1 in 5 US women report delayed contraceptive initiation after sexual debut
Endocrinology

Statin use may reduce risk of venous thromboembolism in women taking hormone therapy

December 21, 2023
Next Post
Buccal administration of dextrose gel effective for neonatal hypoglycemia

Postresuscitation care may be needed regardless of PPV duration

Dexamethasone shows comparable efficacy to prednisone/prednisolone in pediatric asthma

Continuous albuterol thought to be safe in floor setting

Intravenous contrast may not increase risk of acute kidney injury

Fenoldopam ineffective for renal injury after cardiac surgery

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Children with autism spectrum disorder may have reduced fecal microbial diversity
  • Variable homicide mortality rates among women aged 15-44 years depending on state abortion policy
  • An artificial intelligence model demonstrates the potential for improving the efficiency of structural heart disease screening using electrocardiograms
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.